Research library
Surgery Partners, Inc. (SGRY): the bull case and the bear case
Surgery Partners, Inc. · NASDAQ · Equity · Stock
The synthesis
Pending acquisition by HealthSpan Partners at a significant premium offset by high leverage and overbought technical indicators.
- Definitive acquisition agreement
HealthSpan Partners entered a definitive agreement to acquire the company for an enterprise value of $5.7 billion, as disclosed on 8-K Item 1.01 on October 26, 2024.
- Strong same-facility performance
Per the 10-Q, days-adjusted same-facility revenues increased 5.0% in Q2 2026, demonstrating organic growth and higher case volumes across its diversified surgical platform.
- Robust price momentum
The stock is trading significantly above its 50-day and 200-day moving averages, supported by a positive MACD of +0.38 following news of the all-cash transaction.
- Significant debt burden
The company carries $3.8 billion in net debt against a $3.0 billion market cap, resulting in a high debt-to-equity ratio of 2.40 and negative ROE of -5.2%.
- Overbought technical signals
A Stochastic %K of 86.1 and an RSI of 64.2 suggest the stock is in overbought territory as it approaches its 52-week high resistance level of $23.44.
- Transaction completion risk
The 10-Q notes the risk that potential sale transactions may not be completed in a timely manner or at all, which could trigger a sharp reversal if the deal fails.
Catalysts
- Acquisition closing Near-term
- Regulatory approval Ongoing
- Q3 earnings release Nov 2026
Risks
- Deal termination High impact
- Net debt load $3.8B
- Payment reductions Government/Private
What would change the view
A successful and timely close of the HealthSpan acquisition would solidify the bull case and provide immediate liquidity to shareholders. Conversely, any regulatory hurdles or financing delays that threaten the deal would likely cause the stock to retreat toward its pre-announcement moving averages near 14.44.
Insider activity
Open-market purchases and sales reported by company insiders on SEC Form 4, from EDGAR. Share counts and dates only.
Sources
- FMP · SGRY daily prices and technical indicators Analyst note
- FMP · SGRY financial statements (income / balance / cash flow) SEC filing
- SEC EDGAR · SGRY full-text filing search SEC filing
- SEC · SCHEDULE 13D/A filed 2026-10-26 SEC filing · SCHEDULE 13D/A · 2026-10-26
- SEC · DEFA14A filed 2026-10-26 SEC filing · DEFA14A · 2026-10-26
- SEC · 8-K filed 2026-10-26 (Items 1.01, 7.01, 9.01) SEC filing · 8-K · 2026-10-26
- SEC · SCHEDULE 13G filed 2026-10-13 SEC filing · SCHEDULE 13G · 2026-10-13
- SEC · 8-K filed 2026-09-17 (Items 2.01, 9.01) SEC filing · 8-K · 2026-09-17
- SEC · 4/A filed 2026-08-20 SEC filing · 4/A · 2026-08-20
- SEC · 4 filed 2026-08-19 SEC filing · 4 · 2026-08-19
- SEC · SCHEDULE 13G filed 2026-08-14 SEC filing · SCHEDULE 13G · 2026-08-14
- SEC · 10-Q filed 2026-08-10 SEC filing · 10-Q · 2026-08-10
- SEC · 8-K filed 2026-08-10 (Items 2.02, 7.01, 9.01) SEC filing · 8-K · 2026-08-10
- Business Wire · HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform News
- Benzinga · Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket News
Read the full analysis in the app
This page publishes the written thesis. The app adds the sections not published here:
- Fundamentals
- Technicals
- News with bull, bear, and neutral tags
- 7-day news sentiment and earnings-call tone
- Forward analyst estimates
- Earnings-call summary
